市場調查報告書
商品編碼
1029166

蛋白質治療藥的全球市場 (2021-2026年):產業趨勢、市場佔有率、市場規模、成長預測、市場機會

Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球蛋白質治療藥的市場規模在預測期間中預計以約6%的年複合成長率成長。

慢性疾病增加,盡力抑制副作用的風險,效率性高等,蛋白質治療藥的優點相關認識的高漲等要素促進該市場的成長。單株抗體,廣泛研究、使用在各種病毒性疾病和細菌性疾病的治療,製藥企業利用蛋白質治療藥於藥物研發、開發。還有新型冠狀病毒感染疾病 (COVID-19)的發生對進入經營者也表現進一步成長機會。

本報告提供全球蛋白質治療藥的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,市場規模的變化、預測,產品、治療領域、功能、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 調查範圍、調查手法

第3章 摘要整理

第4章 簡介

第5章 世界市場趨勢

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 市場分析、預測:各產品

  • 單株抗體(mAbs)
  • 胰島素注射液
  • 促血紅細胞生長素
  • 凝血因子
  • 融合蛋白質
  • 其他

第7章 市場分析、預測:各治療領域

  • 代謝障礙
  • 免疫障礙
  • 造血系疾病
  • 癌症
  • 荷爾蒙障礙
  • 遺傳性疾病
  • 其他

第8章 市場分析、預測:各功能

  • 酵素、調節
  • 標靶化
  • 疫苗
  • 蛋白質診斷

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 亞太地區
  • 歐洲
  • 南美
  • 中東、非洲

第10章 SWOT分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 價格分析

第14章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Amgen Inc.
    • Abbott Laboratories
    • Abbvie Inc.
    • Baxter International Inc.
    • Biogen Inc.
    • Csl Behring L.L.C.(CSL Limited)
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG(Roche Holding AG)
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Novo Nordisk A/S(Novo Holdings A/S)
    • Pfizer Inc.
目錄
Product Code: SR1020F116_Report

The global protein therapeutics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.

Protein therapeutics refers to artificially synthesized protein-based medicines. They are fast-acting, potent medicines that deliver small protein molecules to the body in a specific amount. They usually consist of recombinant forms of naturally occurring proteins, such as monoclonal antibodies, insulin, fusion proteins, erythropoietin, interferon, human growth hormones (HGH) and follicle-stimulating hormones. They aid in treating chronic medical ailments, such as cancer, diabetes, neurodegenerative disorders and immunological, hematological, hormonal and genetic disorders. Various combination therapy drugs are also used with protein therapeutics that can be inhaled, injected or orally administered.

Global Protein Therapeutics Market Trends and Drivers:

  • The increasing prevalence of chronic medical ailments is one of the key factors driving the growth of the protein therapeutics market. In line with this, the rising awareness among the masses regarding the benefits of protein therapeutics, such as minimal risks of side effects and high efficiency, are contributing to the market growth. Monoclonal antibodies are being widely researched and used for the treatment of various viral and bacterial diseases and pharmaceutical companies are using protein therapeutics for drug discovery and development. The sudden outbreak of the coronavirus disease (COVID-19) is further providing growth opportunities to market players. For instance, Molecular Partners AG, a Switzerland-based clinical stage biotechnology company, is developing a new class of protein therapeutics, called DARPin®, to inhibit the proliferation of the virus.
  • The development of novel recombinant proteins, peptides, antibody-based drugs and plasma proteins is acting as other-growth inducing factors. These protein therapeutics are extensively used in replacement therapies to treat genetic and autoimmune disorders, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. Other factors, including extensive research and development (R&D) activities in the field of protein engineering, along with significant improvements in the healthcare infrastructure, are expected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global protein therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, therapy area and function.

Breakup by Product:

  • Monoclonal Antibodies (mAbs)
  • Human Insulin
  • Erythropoietin
  • Clotting Factors
  • Fusion Protein
  • Others

Breakup by Therapy Area:

  • Metabolic Disorders
  • Immunological Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

Breakup by Function:

  • Enzymatic and Regulatory Activity
  • Special Targeting Activity
  • Vaccines
  • Protein Diagnostics

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Amgen Inc., Abbott Laboratories, Abbvie Inc., Baxter International Inc., Biogen Inc., Csl Behring L.L.C. (CSL Limited), Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding AG), Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S (Novo Holdings A/S) and Pfizer Inc. Key Questions Answered in This Report:

  • How has the global protein therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global protein therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the therapy area?
  • What is the breakup of the market based on the function?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global protein therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Protein Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Monoclonal Antibodies (mAbs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Human Insulin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Erythropoietin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Clotting Factors
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Fusion Protein
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Therapy Area

  • 7.1 Metabolic Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunological Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hematological Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Hormonal Disorders
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Genetic Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Function

  • 8.1 Enzymatic and Regulatory Activity
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Special Targeting Activity
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Vaccines
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Protein Diagnostics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Abbvie Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Biogen Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Csl Behring L.L.C. (CSL Limited)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Eli Lilly and Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Johnson & Johnson
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Merck & Co. Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Novo Nordisk A/S (Novo Holdings A/S)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Protein Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Protein Therapeutics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Protein Therapeutics Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Protein Therapeutics Market: Breakup by Therapy Area (in %), 2020
  • Figure 5: Global: Protein Therapeutics Market: Breakup by Function (in %), 2020
  • Figure 6: Global: Protein Therapeutics Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Protein Therapeutics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Protein Therapeutics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 9: Global: Protein Therapeutics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 10: Global: Protein Therapeutics (Human Insulin) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Protein Therapeutics (Human Insulin) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Protein Therapeutics (Erythropoietin) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Protein Therapeutics (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Protein Therapeutics (Clotting Factors) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Protein Therapeutics (Clotting Factors) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Protein Therapeutics (Fusion Protein) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Protein Therapeutics (Fusion Protein) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Protein Therapeutics (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Protein Therapeutics (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Protein Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Protein Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Protein Therapeutics (Immunological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Protein Therapeutics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Protein Therapeutics (Hematological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Protein Therapeutics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Protein Therapeutics (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Protein Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Protein Therapeutics (Hormonal Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Protein Therapeutics (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Protein Therapeutics (Genetic Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Protein Therapeutics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Protein Therapeutics (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Protein Therapeutics (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Protein Therapeutics (Enzymatic and Regulatory Activity) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Protein Therapeutics (Special Targeting Activity) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Protein Therapeutics (Special Targeting Activity) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Protein Therapeutics (Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Protein Therapeutics (Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Global: Protein Therapeutics (Protein Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Global: Protein Therapeutics (Protein Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: North America: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: North America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: United States: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: United States: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Canada: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Canada: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Asia Pacific: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Asia Pacific: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: China: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: China: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: Japan: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: Japan: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: India: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: India: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: South Korea: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: South Korea: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Australia: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Australia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Indonesia: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Indonesia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Europe: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Europe: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Germany: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Germany: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: France: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: France: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: United Kingdom: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: United Kingdom: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Italy: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Italy: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Spain: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Spain: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Russia: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: Russia: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Latin America: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Latin America: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Brazil: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 83: Brazil: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 84: Mexico: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 85: Mexico: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 86: Others: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 87: Others: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 88: Middle East and Africa: Protein Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 89: Middle East and Africa: Protein Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 90: Global: Protein Therapeutics Industry: SWOT Analysis
  • Figure 91: Global: Protein Therapeutics Industry: Value Chain Analysis
  • Figure 92: Global: Protein Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Protein Therapeutics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Protein Therapeutics Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Protein Therapeutics Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
  • Table 4: Global: Protein Therapeutics Market Forecast: Breakup by Function (in Million US$), 2021-2026
  • Table 5: Global: Protein Therapeutics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Protein Therapeutics Market Structure
  • Table 7: Global: Protein Therapeutics Market: Key Players